The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...